The invention
Establishment of DNA Replication-initiation Proteins as Novel Anticancer Targets (DRIPs) and Development of First-in-class Anticancer Drug Candidates Targeting DRIPs
The invention
- Name of invention
- Establishment of DNA Replication-initiation Proteins as Novel Anticancer Targets (DRIPs) and Development of First-in-class Anticancer Drug Candidates Targeting DRIPs
- Établir des protéines d'initiation de la réplication de l'ADN en tant que nouvelles cibles anticancéreuses (DRIPs) et développer des candidats anticancéreux de première classe ciblant les DRIPs.
Invention description
- Description
- Established DNA replication-initiation proteins (DRIPs) as novel anticancer targets and identified DRIP inhibitors as potent broad-spectrum anticancer drug candidates without harm to normal cells; one is safe and effective in phase II clinical trial.
INVENTORS
THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY inventor 3700652863_2972
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.